Spirometry, 1996 update

Respiratory Care

Volumn 41, Issue 7, 1996, Pages 629-636

  Shrake, Kevin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748107695     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. American Association for Respiratory Care. Clinical practice guideline: spirometry. Respir Care 1991; 136: 1414-1417.
2. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:10391060. Published concurrently in Respir Care 1987;32(11): 1039-1060.
3. American Thoracic Society. Standardization of spirometry 1994 update. Am J Respir Crit Care Med 1995; 152 (3): 1107-1136.
4. Ferns BG. Epidemiology standardization project. Am Rev Respir Dis 1979;! 18(Suppl):7-13).
5. American Thoracic Society. Evaluation of impairment/ disability secondary to respiratory disorders. Am Rev Respir Dis 1986;133(6):1205-1209.
6. Zibrak JD, O'Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med 1990; 112:793-794.
7. Hankinson JL. Pulmonary function testing in the screening of workers: guidelines for instrumentation, performance, and interpretation. J Occup Med 1986;28: 1081-1082.
8. Crapo RO. Pulmonary function testing. N Engl J Med 1994;331:25-30.
9. Miller WF, Scacci R, Gast LR. Laboratory evaluation of pulmonary function. Philadelphia: JB Lippincott Co, 1987.
10. Montenegro HD, Chester EH, Jones PK. Cardiac arrhythmias during routine tests of pulmonary function in patients with chronic obstruction of airways. Chest 1978;73:133-139.
11. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis 1991;143(3):516-521.
12. Enright PL, Johnson LR, Connett JE, Voelker H, Buist AS. Spirometry in the lung health study: 1. Methods and quality control. Am Rev Respir Dis 1991;143(6): 1215-1223.
13. Casaburi R, Adame D, Hong CK. Comparison of albuterol to isoproterenol as a bronchodilator for use in pulmonary function testing. Chest 1991 ;100:1597-1600.
14. Light RW, Conrad SA, George RB. Clinical significance of pulmonary function tests-the one best test for evaluating the effects of bronchodilator therapy. Chest 1977;72:512-516.
15. Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to bronchodilator: epidemiologic considerations. Am Rev Respir Dis 1988;138(2):317-320.
16. Shim C. Response to bronchodilators. Clin Chest Med 1989;10:155-164.
17. Waalkens HJ, Merkus PJE, can Essen-Zandvliet EEM, et al, Assessment of bronchodilator response in children with asthma. Eur Respir J 1993;6:645-651.
18. American Thoracic Society Workshop on Lung Function Testing, Becklare M, Crapo RO, co-chairpersons. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144 (5):1202-1218.
19. American Association for Respiratory Care. Clinical practice guideline: assessing response to bronchodilator therapy at point of care. Respir Care 1995;40: 1300-1307.
20. Hepper NGG, Black LF, Fowler WS. Relationship of lung volume to height and arm span in normal subjects and in patients with spinal deformity. Am Rev Respir Dis 1965;91:356-362.
21. McKay RT, Lockey JE. Pulmonary function testing: guidelines for medical surveillance and epidemiological studies. Occup Med 1991;6:43-57.
22. Morris AH, Kanner RE, Crapo RO, Gardner RM. Clinical pulmonary function testing: a manual of uniform laboratory procedures, 2nd ed. Intermountain Thoracic Society, 1984, Salt Lake City.
23. American Association for Respiratory Care. Clinical practice guideline: resuscitation in acute care hospitals. Respir Care 1993;38(11): 1169-1200.
24. Glindmeyer HW, Jones RN, Barkman HW, Weill H. Spirometry: quantitative test criteria and test acceptability. Am Rev Respir Dis 1987;136(2):449-452.
25. Shigeoka JW. Calibration and quality control of spirometer systems. Respir Care 1983;28(6):747-753.
26. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood borne pathogens in health care settings. MMWR 1988;37: 377-388.
27. Centers for Disease Control. Summary: recommendations for preventing transmission of infection with human T-lymphotrophic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985; 34:681,686, 691-695.
28. Garner JS, Favero MS. CDC guidelines for the prevention and control of nosocomial infections: guideline for hand washing and hospital environmental control. Am J Infect Control 1986;14:110-129.
29. Tablan OC, Williams WW, Marione WJ. Infection control in pulmonary function laboratories. Infect Control 1985;6:442-444.
30. Rutala DR, Rutala WA, Weber DR, et al. Infection risks associated with spirometry. Infection Control Hospital Epidemiol 1991; 12:89-92.
31. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR 1994; 43:1-32.
32. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994; 43:1-132.
33. Johns DP, Ingram C, Booth H, Williams TJ, Walters EH. Effect of a microaerosol barrier filter on the measurement of lung function. Chest 1995;107(4): 1045-1048.
34. Fuso L, Accardo D, Bevignani G, et al. Effects of a filter at the mouth on pulmonary function tests. Eur Respir J 1995; 8:314-317.